March 23, 2025

Vutrisiran Snags FDA Approval for TTR Amyloidosis Cardiomyopathy

March 21, 2025

MedPage Today) — Gene-silencing therapy vutrisiran (Amvuttra) graduated to a broad indication in treatment of transthyretin amyloidosis cardiomyopathy, as Alnylam Pharmaceuticals announced expanded FDA approval. Vutrisiran, a transthyretin-directed…

MedPage Today) — Gene-silencing therapy vutrisiran (Amvuttra) graduated to a broad indication in treatment of transthyretin amyloidosis cardiomyopathy, as Alnylam Pharmaceuticals announced expanded FDA approval.
Vutrisiran, a transthyretin-directed…
Read More

About Author

Tomi Lanz

See author's posts

More Stories

Second TB vaccination boosts immunity in bladder cancer patients and reduces cancer recurrence, pilot study suggests

March 22, 2025

Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

March 22, 2025

Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women

March 22, 2025

You may have missed

Second TB vaccination boosts immunity in bladder cancer patients and reduces cancer recurrence, pilot study suggests

Second TB vaccination boosts immunity in bladder cancer patients and reduces cancer recurrence, pilot study suggests

March 22, 2025
Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

March 22, 2025
Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women

Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women

March 22, 2025
Automated insulin delivery improves glycemic control of type 2 diabetes in randomized trial

Automated insulin delivery improves glycemic control of type 2 diabetes in randomized trial

March 22, 2025
New bill targets harmful ingredients in California school food

New bill targets harmful ingredients in California school food

March 22, 2025